ABcann Medicinals Receives Full Facility Approval from Health Canada

NAPANEE, ON / ACCESSWIRE / July 16, 2015 / On July 10, 2015 ABcann Medicinals received its full facility approval from Health Canada. Through this approval, ABcann will now be able to flower the plants they currently have growing and put it through the necessary testing prior to sale.

"Full room approval has been provided and dictates that all bloom rooms, growth chambers, vegetation room, clean/general horticulture rooms, processing and drying areas, as well as ABcann's in house laboratory, have been given Health Canada's blessing to commence full production activities," says Tim Humberstone, Senior Person In-Charge at ABcann.

ABcann has been preparing for this approval for many months and is very excited to be able to grow in every room at the facility. ABcann's production cycle began in January 2015 with the planting of the first set of seeds and has been waiting since to further the growth process for their overall goal of standardization. When asked about ABcann's process with Health Canada so far, Tim Humberstone stated, "Recent communications and discussions with Health Canada has provided extremely positive feedback from our partners and we strongly feel that our path to provide standardized medicine was the right choice."

ABcann expects to sell a combination of High THC, High CBD and Blended THC and CBD strains that will be subject to rigorous third-party testing. Once internal and external testing has been completed, specific values of THC and CBD genetics will be available. Through this process, each ABcann strain will be certified by Tru-ID, a company that authenticates food and natural health products. Tru-ID has entered into an exclusive partnership with ABcann to authenticate medical cannabis. "Once our products are tested and the results approved by Health Canada, ABcann Medicinals Inc. expect to be providing clients with our medical cannabis in the very near future," says Humberstone on product availability.

This room approval came in the midst of a defining moment for medical cannabis in Canada. On July 8, 2015 Health Canada issued a statement that issued a Section 56 exemption under the Controlled Drugs and Substances Act (CDSA) allowing licensed producers to produce and sell cannabis oil and fresh cannabis. ABcann is in the process of applying to develop cannabis oil to allow for patients choice in their medical cannabis. The cannabis oil produced at ABcann will also undergo the same testing procedures as dried cannabis and will carry the same certifications to ensure standardization of the product.

ABcann is currently working on determining which strains and THC/ CBD levels will be available in the cannabis oil. For more updates on product availability and registration dates, please visit www.abcann.ca

About ABcann Medicinals Inc.

ABcann Medicinals Inc. is an approved Licensed Producer under the Marihuana for Medical Purposes Regulations (MMPR). We believe the success of the pharmaceutical industry was based on their ability to manufacture medicine achieved through methods of precision, quality controls, high standards and good manufacturing practices. ABcann has structured our vision to align with these principles. We've developed a system capable of producing standardized chemical compounds derived from plants. This unique technology sets us apart from the traditional competitors in the cannabis industry. Experts agree this is the only way to grow plants to be accepted as medicine.

Professor Raphael Mechoulam states:

"Your effort to have Cannabis crops fully standardized from batch to batch moves Cannabis treatment closer to the drug standards generally accepted by physicians and patients and represents an important and very valuable step."

www.ABcann.ca
www.twitter.com/abcannmed
www.linkedin.com/abcannmed

For Media Inquires Contact:

info@abcann.ca
1-855-322-2266

SOURCE: ABcann Medicinals Inc.